Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Nissan Chem. reveals new antidiabetic agents

May 28, 1997

MP-52 to be developed worldwide by HMR

May 27, 1997

Lilly describes new agents for postmenopausal syndrome

May 26, 1997

Squalene synthase inhibitors from Takeda

May 26, 1997

Celtrix receives additional U.S. patents

May 23, 1997

Alora launched in U.S.

May 22, 1997

Merck updates development of higher dose Zocor

May 21, 1997

Positive phase II/III results for Cortecs' Macritonin

May 20, 1997

FDA advisory committee recommends Roche's Xenical for weight loss

May 15, 1997

FDA approves Columbia's Crinone

May 15, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...